Evidence map›Paper›PMID 35061514›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Reply to S. Ning et al.

Elizabeth A Salerno, Eva Culakova, Charles E Heckler, Michelle C Janelsins

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Elizabeth A SalernoElizabeth A. Salerno, PhD, MPH, Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine in St Louis, St Louis, MO; and Eva Culakova, PhD, Charles E. Heckler, PhD, and Michelle C. Janelsins, PhD, MPH, Department of Surgery, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0001-5152-3168
Eva CulakovaElizabeth A. Salerno, PhD, MPH, Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine in St Louis, St Louis, MO; and Eva Culakova, PhD, Charles E. Heckler, PhD, and Michelle C. Janelsins, PhD, MPH, Department of Surgery, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0002-9852-6515
Charles E HecklerElizabeth A. Salerno, PhD, MPH, Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine in St Louis, St Louis, MO; and Eva Culakova, PhD, Charles E. Heckler, PhD, and Michelle C. Janelsins, PhD, MPH, Department of Surgery, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
Michelle C JanelsinsElizabeth A. Salerno, PhD, MPH, Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine in St Louis, St Louis, MO; and Eva Culakova, PhD, Charles E. Heckler, PhD, and Michelle C. Janelsins, PhD, MPH, Department of Surgery, University of Rochester Medical Center, Rochester, NY, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.ORCID 0000-0003-2258-7247

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASEU10CA037420 · NCI · UNIVERSITY OF ROCHESTER · PI MORROW, GARY R · 1985 to 2014
$21.1M
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and FunctionR01CA231014 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C · 2019 to 2024
$3.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive ProblemsK07CA168886 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C · 2013 to 2017
$724k
NCI NIH HHS K07 CA168886NCI NIH HHS R01 CA231014NCI NIH HHS T32 CA102618NCI NIH HHS U10 CA037420NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCognitionExerciseFemaleHumansProspective Studies

Identifiers

PMID35061514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.